companies / cutiss-swiss
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-06 json
| total_raised | 61,600,00061.6M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | Zurich | |
| industry | unknown | |
| stage | series-b+ |
Cutiss is a biotech developing personalized, lab-grown human skin grafts produced through automated manufacturing. Its denovoSkin therapy is aimed at patients needing skin surgery, including severe burns and reconstructive cases. Its differentiator is a patented, fully closed, end-to-end automation platform that enables decentralized, scalable production of living personalized skin.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-09-01 | series-c | 61,600,00061.6M | null | ○ |
WordPress 6.9.4, Apache HTTP Server, Astra 4.13.1, reCAPTCHA, Google Analytics, Google Sign-in, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, parallax.js 1.0, particles.js, DoubleClick Floodlight
| fact | status | src |
|---|---|---|
| Series C, $61.6M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |